StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson operational (constant-currency) adjusted diluted EPS ($) ($)

Form 8-K EX-99.2 Reconciliation of Non-GAAP Financial Measures

Latest, FY2025
10.58
Period ended Dec 28, 2025
Change on a year earlier
+5.9%
9.99 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperational (constant-currency) adjusted diluted EPS ($) ($)Year on yearSource
FY2025Dec 28, 202510.58+5.9%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
FY2024Dec 29, 20249.99+1.0%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
FY2023Dec 31, 20239.89-7.6%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗
FY2022Jan 1, 202310.70+10.9%Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2021Jan 2, 20229.65+20.6%Form 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2020Jan 3, 20218-10.1%Form 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2019Dec 29, 20198.90+22.9%Form 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 20187.24+6.8%Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 20176.78–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Operational (constant-currency) adjusted diluted EPS ($) ($), annual FY2017–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ops_adj_eps_diluted

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.